Thus, some mechanistic overlap between CPVT and LQTS caused by CaM mutations likely exist, and how arrhythmogenic CaM mutations manifest probably depends on their relative effects on RyR2, CaV1.2, and other CaM-regulated targets. This evidence concerns the gene CACNA1C and catecholaminergic polymorphic ventricular tachycardia.